Sisu Global Health net grant to develop Hemafuse to address internal bleeding from pregnancy complications
Sisu Global Health, a Michigan-based medical device company, announces the full acceptance of the Saving Lives at Birth: A Grand Challenge for Development grant, to develop and implement the Hemafuse to address internal bleeding from pregnancy complications. Saving Lives at Birth is a global competition for technologies impacting infant and maternal health supported by the U. S. Agency for International Development, the Gates Foundation, Grand Challenges Canada, the Norwegian Ministry of Foreign Affairs and UKAID. With the grant, Sisu Global Health will launch its business pilot in Ghana. Sisu has worked with hospitals in Ghana to develop this device over the past 4 years, and has recently received interest from other Sub-Saharan African countries.
Sisu Global Health designs and develops medical technology for hospitals and clinics in low-resource countries. Their winning technology is an autologous transfusion device to recycle blood from an internal hemorrhage. Frequent causes of internal hemorrhages in Sub-Saharan Africa come from early pregnancy complications and blunt trauma incidents such as traffic accidents. Maternal mortality is high in Sub-Saharan Africa, often caused by hemorrhage and the inability to prevent it.
As a follow-up to the grant, Sisu Global Health is sponsoring a crowdfunding campaign which started Mid-December. You can find out about the campaign on its Indiegogo page at http://igg.me/at/fundsisu. This crowdfund campaign will fund a training workshop in Zimbabwe, where the company has also been invited to launch the product in addition to its pilot in Ghana.
“This opportunity in Zimbabwe would allow us to springboard getting our device in the hands of doctors to save lives. Sisu is in the midst of a ‘pioneer gap’ as far as funding to really prove its new model,” said Carolyn Yarina, CEO of Sisu. “This award will go a long way in helping us continue the lifesaving work we’re doing in Ghana and in other developing nations.”
“It’s not just a matter of making things cheaper, or simplifying technologies,” continued Gillian Henker, chief technology officer of Sisu. “A lot of people in the developing world are highly educated and technically trained; it’s more shifting our thinking to fit their specific needs. What we need and have access to in the Western world isn’t always appropriate or supportive.”
About Sisu Global Health
Based out of GR Current, a life sciences incubator in Grand Rapids, Michigan, the company is led by three women: Carolyn Yarina (CEO), Gillian Henker (Chief Technology Officer), and Katherine Kirsch (Chief Marketing Officer). The startup intends to maintain its headquarters in Grand Rapids, Mich., and intentionally scale their impact in a for-profit model. Sisu has conducted on-the-ground research in both India and Ghana on their portfolio products, including the Hemafuse, a mechanical blood transfusion device. For more information, visit www.sisuglobalhealth.com
“This press release is made possible through the generous support of the Saving Lives at partners: the United States Agency for International Development (USAID), the Government of Norway, the Bill & Melinda Gates Foundation, Grand Challenges Canada, and the UK Government. It was prepared by Sisu Global Health and does not necessarily reflect the views of the Saving Lives at Birth partners.”